Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - ImmunoGen
 More »

  • GEN | Biolinks
    ... Illinois-Missouri Biotechnology Alliance Illumina ImmunoCellular Therapeutics ImmunoGen Imperial College London Incyte InDevR Indiana Economic Development Corporation ...
  • Astellas, Ambrx Launch Up-To-$300M ADC Partnership
    Ambrx is among biotechs that have focused on developing ADCs, hoping to follow in the successful footsteps of drug developers like Roche's Genentech unit and ImmunoGen, which won ...
    4-5-2013
  • Roche's Genentech Wins FDA OK for Breast Cancer Drug
    HER2 protein, Kadcyla was developed by ImmunoGen, and joins three other HER2-positive ... However, ImmunoGen will yet benefit from Kadcyla's approval. While the company was ...
    2-22-2013
  • People in the News
    Before joining Amgen, he was at Dynavax Technologies. Orgenesis appointed Camillo Ricordi, M.D. , to its scientific advisory board...ImmunoGen hired Charles Morris as evp and chief ...
    1-1-2013
  • GEN Reports on Growing Interest in Antibody-Drug Conjugates
    it. Other companies in the GEN article include Ambryx Biotechnology, Spirogen, ADC Therapeutics, Mersana Therapeutics, Seattle Genetics, Roche/Genentech, ImmunoGen, and Pfizer.
    12-10-2012
  • Cancer Research Firms Eye ADCs to Extend Portfolios
    ... ADCs," Chew says, "and collaborates with ImmunoGen, Seattle Genetics, and several others. ... breast cancer with the FDA and EMA. ImmunoGen ImmunoGen has 18 projects in development ...
    12-1-2012
  • 15 Breast Cancer Drugs in the Pipeline Right Now
    ... Trastuzumab emtansine; RG3502) Sponsor: Roche, with linker technology developed by ImmunoGen Method of Action: Antibody-drug conjugate, consisting of the antibody trastuzumab and ...
    11-26-2012
  • Mouse Monoclonal IgM Antibody
    ANPEG-1 is a mouse monoclonal IgM antibody developed using a linear 40 kDa PEG polymer immunogen. It has been used as a positive control antibody in double-bridging immunogenicity ...
    11-15-2012
  • The Importance of Immunogen Selection for Successful Antibodies

    11-1-2012
  • 10 Tips for Selecting The Right Antibody
    They will also dictate what type of immunogen your antibody should have been raised ... Check immunogen details to be doubly sure your antibody will tell you what you want to ...
    8-13-2012
  • Why The AIDS Vaccine Remains Elusive
    Discovering how that happens will be the goal of two new Centers for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID), one of which will be led by Dr. Haynes at Duke. ...
    8-6-2012
  • Monoclonal Antibodies Enter Golden Age
    Although CHO cells are currently the most popular mAb-producing cells, as second-generation expression systems enter clinical trials and commercialization, Cytovance scientists ...
    8-1-2012
  • Duke, Scripps to Anchor New NIAID-Funded HIV/AIDS Center
    $186 million or more over seven years, to Duke University and The Scripps Research Institute for the new Centers for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID). ...
    7-13-2012
  • Genentech Plans 2012 U.S./EU Filing for T-DM1 in Metastatic Her2...
    Trastuzumab emtansine comprises trastuzumab (Herceptin®) and ImmunoGen's DM1 cancer-killing agent, joined using ImmunoGen linker technology. The Emilia study showed that in ...
    6-4-2012
  • Dako, Genentech Ink Second Companion Diagnostic Partnership
    Dako signed an agreement with Genentech to collaborate on FDA regulatory submissions of two Dako tests as companion diagnostics for Genentech's trastuzumab emtansine (T-DM1), a ...
    5-1-2012
  • More »

    Journal Articles

  • Toward Development and Production of Human T Cells in Swine for...
    Brenda M. Ogle, Bruce E. Knudsen, Ryuta Nishitai, Kiyoshi Ogata, Jeffrey L. Platt
    Tissue Engineering, Part A
    These measures may fail if the treated individual lacks T cells specific for the immunogen(s). We tested another strategy-the generation of new T cells from hematopoietic stem ...
  • Production of Monoclonal Antibody to Acaricide Dicofol and Its...
    Surat Hongsibsong, Tippawan Prapamontol, Chaisuree Suphavilai, Jiraprapa Wipasa, Mookda Pattarawarapan, Watchara Kasinrerk
    Hybridoma
    DCBH-BSA conjugate was used as immunogen while DCBH-OVA conjugate was used as capture antigen for competitive inhibition assay. Female BALB/c mice were immunized with DCBH-BSA ...
  • Antioxidant Bioavailability and Rapid Immune-Modulating Effects...
    Gitte S. Jensen, Kimberlee A. Redman, Kathleen F. Benson, Steve G. Carter, Marcie A. Mitzner, Stuart Reeves, Larry Robinson
    Journal of Medicinal Food
    Antioxidant Bioavailability and Rapid Immune-Modulating Effects After Consumption of a Single Acute Dose of a High-Metabolite Yeast Immunogen: Results of a Placebo-Controlled ...
  • Production of Polyclonal Antibody Against Alkyl Hydroperoxide...
    Taher Mohammadian, Mahmoud Doosti, Maliheh Paknejad, Farideh Siavoshi, Sadegh Massarrat, Mohammad Soukhtanloo
    Hybridoma
    by column chromatographic techniques, which may also decrease the purity of the immunogen. The present method is simple, rapid and cost-effective, and also makes it possible ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll